- ALT +2.51%
Altimmune, Inc. (ALT): Why Are Hedge Funds Shorting This Biopharmaceutical Stock?
Yahoo Finance · 12 hours ago
Open | 6.39 |
High | 6.67 |
Low | 6.30 |
Mkt Cap | 464.05M |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 6.39 |
52 Wk. Low | 2.09 |
52 Wk. High | 14.84 |
Related stocks
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 5k | 76.20% ▼ |
Net Income | -24.39M | - |
Diluted EPS | -0.34 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | -$0.34 | - |
Q1 2024 | -$0.37 | -$0.34 |
Q4 2023 | -$0.43 | -$0.54 |
S&P 500^GSPC | 5,480.24-2.63 (-0.05%) |
Dow 30^DJI | 39,124.78-39.28 (-0.10%) |
Nasdaq^IXIC | 17,836.52-22.17 (-0.12%) |
NIKE, Inc.NKE | 75.29-20.07% |
34.55-5.93% | |
Tesla, Inc.TSLA | 196.84-0.29% |